The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease response at apheresis and association with long-term outcomes following CAR-T cells for relapsed/refractory multiple myeloma (RRMM).
 
Thomas Luo
Stock and Other Ownership Interests - Verve Therapeutics
 
Luca Paruzzo
No Relationships to Disclose
 
Sandra Susanibar Adaniya
Consulting or Advisory Role - Sanofi
 
Alfred Garfall
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; CDR-Life; GlaxoSmithKline; Janssen Oncology; Novartis; Regeneron; Smart Immune
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
Travel, Accommodations, Expenses - Janssen
 
Matthew Ho
No Relationships to Disclose
 
Shivani Kapur
No Relationships to Disclose
 
Marco Ruella
Leadership - viTToria Biotherapeutics
Honoraria - Gerson Lehrman Group; Guidepoint Inc
Consulting or Advisory Role - AbClon; BeiGene; E.R. Squibb Sons, LLC; Gerson Lehrman Group; Guidepoint Inc; Lumicks
Research Funding - AbClon; Beckman Coulter; Lumicks; Oxford Nano Imaging; viTToria Biotherapeutics
Patents, Royalties, Other Intellectual Property - CART technologies; Kite, a Gilead Company; Novartis; University of Pennsylvania; viTTOria Biotherapeutics
Travel, Accommodations, Expenses - Kite, a Gilead Company
Other Relationship - Scientific Founder: viTToria Biotherapeutics
 
Edward Stadtmauer
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Sanofi; Takeda; Teva
 
Federico Stella
No Relationships to Disclose
 
Dan Vogl
Consulting or Advisory Role - Celgene; CSL Behring; Genentech; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda; Takeda
Research Funding - Active Biotech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Karyopharm Therapeutics; Takeda
 
Adam Waxman
No Relationships to Disclose
 
Adam Cohen
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Meyers Squibb; GlaxoSmithKline; Ichnos Sciences; ITeos Therapeutics; Janssen Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ichnos Sciences; Janssen Oncology; Janssen Oncology